Tumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases

Tumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases

Background: Tumor-infiltrating lymphocytes (TILs) were found to be associated with a better clinical outcome in specific subtypes of breast cancer. Aim: To study the association between TILs and the prognosis of Egyptian patients with HER2-negative breast cancer metastatic to the viscera. Methods: T...

Full description

Bibliographic Details
Main Authors: Elia Hakim, Amina Mostafa, Mohamed Mohamed, Mahmoud Sherif, Maha El Naggar
Format: Article
Language:English
Published: Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine 2022-12-01
Series:Research in Oncology
Subjects:
breast cancer
cd4
cd8
her2
prognosis
tumor-infiltrating lymphocytes
visceral metastases
Online Access:https://resoncol.journals.ekb.eg/article_270477_3059978f3da1dc5a0903270e02f2bb30.pdf

Similar Items

Similar Items